This page provides background information on the implementation of the EU Tissue and Cells Directive via the Human Tissue (Quality and Safety for Human Application) Regulations 2007.
The standards that establishments licensed under an HTA post mortem licence should meet
Designated Individuals and Licence Holders under the Human Tissue (Quality and Safety for Human Application) Regulations 2007 (as amended)
Here you will find information on Designated Individuals (DIs) and Licence Holders (LHs) under the Human Tissue (Quality and Safety for Human Application) Regulations 2007
Policy on the management and traceability of tissue samples retained by independent pathologists
Guide to the HTA system for the reporting SAEARs that are linked to the procurement, testing, processing, preservation, storage and distribution of human tissues and cells.
Policy on consent for post-mortem examination and tissue retention under the Human Tissue Act 2004
To help those preparing for a pandemic situation, the HTA has produced guidance on temporary body storage arrangements and licensing requirements.
Information about the regulatory framework applied to Advanced Therapy Medicinal Products (ATMPs)
A Channel 4 Dispatches programme in March 2014 highlighted pregnancy loss and the disposal of fetal remains.
Guidance on the removal of relevant material from deceased children